In particular, mast cell Fc-epsilon receptor (FcεR) signaling is likewise regulated by BTK, making BTK inhibitors a potential treatment for immunoglobulin E (IgE)-related disorders such as allergies, asthma, and dermatitis [11]. This evidence concerns the gene BTK and asthma.